MedTrace Logo

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

NCT02193581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-02-19

No results posted yet for this study

Summary

The use of MDS to access the presence of melanoma in the skin.

Conditions

  • Skin Lesion

Interventions

DEVICE

MDS

Patients with a suspicious lesion, referred for a biopsy is tested using MDS.

Sponsors & Collaborators

  • Hadassah Medical Organization

    collaborator OTHER

  • Orlucent, Inc

    lead INDUSTRY

Principal Investigators

  • Sharon Merims, MD · Hadassah Medical Organization

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-30
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02193581 on ClinicalTrials.gov